No Data
No Data
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Novo Nordisk Stock Crashes on Obesity Drug Data. It's a Win for Eli Lilly. -- Barrons.com
FDA Approves First Medication for Obstructive Sleep Apnea
Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With Obesity
Eli Lilly and Co Options Spot-On: On December 20th, 78,637 Contracts Were Traded, With 362.35K Open Interest
Express News | US FDA Approves Eli Lilly's Zepbound for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity - Website